The Role of Thalidomide in Reversing Cachexia in Patients with Oesophageal Cancer
Completed
- Conditions
- Oesophageal cancerCancer
- Registration Number
- ISRCTN23944748
- Lead Sponsor
- Derby Hospitals NHS Foundation Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Adults with non-obstructing and inoperable oesophageal cancer (dysphagia score <3, able to swallow a semi-solid diet)
Exclusion Criteria
1. Pre-menopausal women
2. Patients receiving any adjuvant chemotherapy or radiotherapy
3. Patients with oesophageal obstruction
4. Those with established neuropathy
5. Patients requiring frequent laser ablation sessions
6. Those unable to maintain an adequate caloric intake
7. Increased debility
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method